nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CHRM3—nephrolithiasis	0.828	1	CbGaD
Oxybutynin—CHRM3—ureter—nephrolithiasis	0.0118	0.49	CbGeAlD
Oxybutynin—Airway obstruction NOS—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0992	CcSEcCtD
Oxybutynin—Hair disorder—Hydrochlorothiazide—nephrolithiasis	0.00741	0.0717	CcSEcCtD
Oxybutynin—Obstructive airways disorder—Hydrochlorothiazide—nephrolithiasis	0.00741	0.0717	CcSEcCtD
Oxybutynin—CHRM5—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00584	0.161	CbGpPWpGaD
Oxybutynin—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00411	0.113	CbGpPWpGaD
Oxybutynin—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00406	0.112	CbGpPWpGaD
Oxybutynin—Oxyphenonium—CHRM3—nephrolithiasis	0.0022	0.26	CrCbGaD
Oxybutynin—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.00214	0.0207	CcSEcCtD
Oxybutynin—CYP3A4—urine—nephrolithiasis	0.00211	0.0875	CbGeAlD
Oxybutynin—CYP2D6—urine—nephrolithiasis	0.00207	0.0861	CbGeAlD
Oxybutynin—Oxyphencyclimine—CHRM3—nephrolithiasis	0.00187	0.221	CrCbGaD
Oxybutynin—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00186	0.018	CcSEcCtD
Oxybutynin—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00181	0.0175	CcSEcCtD
Oxybutynin—Procyclidine—CHRM3—nephrolithiasis	0.00159	0.188	CrCbGaD
Oxybutynin—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00154	0.0149	CcSEcCtD
Oxybutynin—Trihexyphenidyl—CHRM3—nephrolithiasis	0.00145	0.172	CrCbGaD
Oxybutynin—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00141	0.0137	CcSEcCtD
Oxybutynin—Glycopyrrolate—CHRM3—nephrolithiasis	0.00134	0.159	CrCbGaD
Oxybutynin—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00134	0.013	CcSEcCtD
Oxybutynin—Injury—Hydrochlorothiazide—nephrolithiasis	0.00133	0.0129	CcSEcCtD
Oxybutynin—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00132	0.0127	CcSEcCtD
Oxybutynin—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00131	0.0126	CcSEcCtD
Oxybutynin—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0013	0.0126	CcSEcCtD
Oxybutynin—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00129	0.0125	CcSEcCtD
Oxybutynin—CHRM5—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00129	0.0356	CbGpPWpGaD
Oxybutynin—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00128	0.0124	CcSEcCtD
Oxybutynin—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00126	0.0122	CcSEcCtD
Oxybutynin—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00122	0.0118	CcSEcCtD
Oxybutynin—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00121	0.0117	CcSEcCtD
Oxybutynin—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0012	0.0116	CcSEcCtD
Oxybutynin—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0012	0.0116	CcSEcCtD
Oxybutynin—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00118	0.0114	CcSEcCtD
Oxybutynin—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00116	0.0112	CcSEcCtD
Oxybutynin—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00114	0.0111	CcSEcCtD
Oxybutynin—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00113	0.0109	CcSEcCtD
Oxybutynin—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00112	0.0108	CcSEcCtD
Oxybutynin—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00112	0.0108	CcSEcCtD
Oxybutynin—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0011	0.0107	CcSEcCtD
Oxybutynin—CHRM5—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00108	0.0299	CbGpPWpGaD
Oxybutynin—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00106	0.0103	CcSEcCtD
Oxybutynin—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00106	0.0102	CcSEcCtD
Oxybutynin—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00106	0.0102	CcSEcCtD
Oxybutynin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.000987	0.00955	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.000981	0.00949	CcSEcCtD
Oxybutynin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.000975	0.00943	CcSEcCtD
Oxybutynin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.000972	0.00941	CcSEcCtD
Oxybutynin—CHRM3—renal system—nephrolithiasis	0.000939	0.039	CbGeAlD
Oxybutynin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.000915	0.00885	CcSEcCtD
Oxybutynin—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.000915	0.00885	CcSEcCtD
Oxybutynin—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.000909	0.025	CbGpPWpGaD
Oxybutynin—CHRM3—kidney—nephrolithiasis	0.000908	0.0377	CbGeAlD
Oxybutynin—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.000897	0.00868	CcSEcCtD
Oxybutynin—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.000897	0.0247	CbGpPWpGaD
Oxybutynin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.000888	0.00859	CcSEcCtD
Oxybutynin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.000883	0.00854	CcSEcCtD
Oxybutynin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.000847	0.0082	CcSEcCtD
Oxybutynin—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00084	0.00813	CcSEcCtD
Oxybutynin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.000838	0.00811	CcSEcCtD
Oxybutynin—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.000832	0.00805	CcSEcCtD
Oxybutynin—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.000814	0.00788	CcSEcCtD
Oxybutynin—CHRM5—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000791	0.0218	CbGpPWpGaD
Oxybutynin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000788	0.00762	CcSEcCtD
Oxybutynin—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000784	0.00759	CcSEcCtD
Oxybutynin—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000764	0.021	CbGpPWpGaD
Oxybutynin—CYP2C8—renal system—nephrolithiasis	0.000762	0.0316	CbGeAlD
Oxybutynin—CYP3A5—nephron tubule—nephrolithiasis	0.000756	0.0314	CbGeAlD
Oxybutynin—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000755	0.0073	CcSEcCtD
Oxybutynin—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000754	0.0208	CbGpPWpGaD
Oxybutynin—CYP2C8—kidney—nephrolithiasis	0.000736	0.0305	CbGeAlD
Oxybutynin—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000735	0.00712	CcSEcCtD
Oxybutynin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.000725	0.00701	CcSEcCtD
Oxybutynin—Tension—Hydrochlorothiazide—nephrolithiasis	0.000722	0.00698	CcSEcCtD
Oxybutynin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00072	0.00697	CcSEcCtD
Oxybutynin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.000714	0.00691	CcSEcCtD
Oxybutynin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.000711	0.00688	CcSEcCtD
Oxybutynin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000693	0.00671	CcSEcCtD
Oxybutynin—CYP3A5—renal system—nephrolithiasis	0.000687	0.0285	CbGeAlD
Oxybutynin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.000682	0.0066	CcSEcCtD
Oxybutynin—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000676	0.00654	CcSEcCtD
Oxybutynin—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.000672	0.0065	CcSEcCtD
Oxybutynin—CYP3A5—kidney—nephrolithiasis	0.000665	0.0276	CbGeAlD
Oxybutynin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.000663	0.00642	CcSEcCtD
Oxybutynin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000659	0.00638	CcSEcCtD
Oxybutynin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00065	0.00629	CcSEcCtD
Oxybutynin—CYP3A5—cortex of kidney—nephrolithiasis	0.000647	0.0269	CbGeAlD
Oxybutynin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000646	0.00625	CcSEcCtD
Oxybutynin—Cough—Hydrochlorothiazide—nephrolithiasis	0.000642	0.00621	CcSEcCtD
Oxybutynin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000626	0.00606	CcSEcCtD
Oxybutynin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000626	0.00606	CcSEcCtD
Oxybutynin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000624	0.00604	CcSEcCtD
Oxybutynin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.000619	0.00599	CcSEcCtD
Oxybutynin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000612	0.00593	CcSEcCtD
Oxybutynin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000605	0.00586	CcSEcCtD
Oxybutynin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0006	0.00581	CcSEcCtD
Oxybutynin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0006	0.00581	CcSEcCtD
Oxybutynin—Shock—Hydrochlorothiazide—nephrolithiasis	0.00059	0.00571	CcSEcCtD
Oxybutynin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000586	0.00567	CcSEcCtD
Oxybutynin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000572	0.00554	CcSEcCtD
Oxybutynin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000561	0.00543	CcSEcCtD
Oxybutynin—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000557	0.0153	CbGpPWpGaD
Oxybutynin—CHRM3—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000555	0.0153	CbGpPWpGaD
Oxybutynin—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00055	0.0151	CbGpPWpGaD
Oxybutynin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000547	0.00529	CcSEcCtD
Oxybutynin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000543	0.00525	CcSEcCtD
Oxybutynin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000539	0.00522	CcSEcCtD
Oxybutynin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000534	0.00516	CcSEcCtD
Oxybutynin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000528	0.00511	CcSEcCtD
Oxybutynin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000522	0.00505	CcSEcCtD
Oxybutynin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000517	0.00501	CcSEcCtD
Oxybutynin—CYP3A4—renal system—nephrolithiasis	0.000516	0.0214	CbGeAlD
Oxybutynin—Pain—Hydrochlorothiazide—nephrolithiasis	0.000513	0.00497	CcSEcCtD
Oxybutynin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000513	0.00497	CcSEcCtD
Oxybutynin—CYP2D6—renal system—nephrolithiasis	0.000508	0.0211	CbGeAlD
Oxybutynin—CYP3A4—kidney—nephrolithiasis	0.000499	0.0207	CbGeAlD
Oxybutynin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000495	0.00479	CcSEcCtD
Oxybutynin—CYP2D6—kidney—nephrolithiasis	0.000491	0.0204	CbGeAlD
Oxybutynin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000491	0.00475	CcSEcCtD
Oxybutynin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000477	0.00461	CcSEcCtD
Oxybutynin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000474	0.00459	CcSEcCtD
Oxybutynin—CHRM5—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000446	0.0123	CbGpPWpGaD
Oxybutynin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000442	0.00428	CcSEcCtD
Oxybutynin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000431	0.00417	CcSEcCtD
Oxybutynin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000425	0.00411	CcSEcCtD
Oxybutynin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000411	0.00397	CcSEcCtD
Oxybutynin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000399	0.011	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.000398	0.011	CbGpPWpGaD
Oxybutynin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000397	0.00384	CcSEcCtD
Oxybutynin—CHRM5—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000386	0.0106	CbGpPWpGaD
Oxybutynin—CHRM5—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000386	0.0106	CbGpPWpGaD
Oxybutynin—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000382	0.0105	CbGpPWpGaD
Oxybutynin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000382	0.00369	CcSEcCtD
Oxybutynin—Rash—Hydrochlorothiazide—nephrolithiasis	0.000378	0.00366	CcSEcCtD
Oxybutynin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000378	0.00366	CcSEcCtD
Oxybutynin—Headache—Hydrochlorothiazide—nephrolithiasis	0.000376	0.00364	CcSEcCtD
Oxybutynin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000356	0.00345	CcSEcCtD
Oxybutynin—CHRM5—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000322	0.00888	CbGpPWpGaD
Oxybutynin—CYP3A5—Biological oxidations—SLC26A1—nephrolithiasis	0.000315	0.00869	CbGpPWpGaD
Oxybutynin—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000314	0.00864	CbGpPWpGaD
Oxybutynin—CHRM3—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000313	0.00862	CbGpPWpGaD
Oxybutynin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000288	0.00794	CbGpPWpGaD
Oxybutynin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000281	0.00773	CbGpPWpGaD
Oxybutynin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00028	0.00771	CbGpPWpGaD
Oxybutynin—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.000273	0.00753	CbGpPWpGaD
Oxybutynin—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000272	0.00749	CbGpPWpGaD
Oxybutynin—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000272	0.00749	CbGpPWpGaD
Oxybutynin—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000269	0.0074	CbGpPWpGaD
Oxybutynin—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000269	0.0074	CbGpPWpGaD
Oxybutynin—CHRM5—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000249	0.00686	CbGpPWpGaD
Oxybutynin—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000227	0.00625	CbGpPWpGaD
Oxybutynin—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000224	0.00618	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000213	0.00588	CbGpPWpGaD
Oxybutynin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000203	0.00559	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—RGS14—nephrolithiasis	0.000188	0.00518	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000175	0.00483	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000173	0.00477	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—RGS14—nephrolithiasis	0.000171	0.0047	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—CHRM3—nephrolithiasis	0.000162	0.00448	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00015	0.00414	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—PTH—nephrolithiasis	0.000149	0.00409	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000148	0.00409	CbGpPWpGaD
Oxybutynin—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000147	0.00404	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000132	0.00365	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000132	0.00364	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000131	0.0036	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—DGKH—nephrolithiasis	0.000127	0.0035	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.00012	0.00331	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—RGS14—nephrolithiasis	0.00012	0.0033	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.000119	0.00327	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—ADCY10—nephrolithiasis	0.000119	0.00327	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—DGKH—nephrolithiasis	0.000115	0.00318	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000114	0.00315	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000113	0.00311	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.000105	0.00288	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—PTH—nephrolithiasis	0.000104	0.00287	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.000103	0.00285	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—RGS14—nephrolithiasis	0.000101	0.00278	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—CHRM3—nephrolithiasis	9.18e-05	0.00253	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	8.94e-05	0.00246	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	8.91e-05	0.00246	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	8.83e-05	0.00243	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GRHPR—nephrolithiasis	8.47e-05	0.00233	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—PTH—nephrolithiasis	8.4e-05	0.00231	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	8.35e-05	0.0023	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—CHRM3—nephrolithiasis	8.34e-05	0.0023	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	8.32e-05	0.00229	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	8.24e-05	0.00227	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	8.12e-05	0.00224	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	8.09e-05	0.00223	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	8.02e-05	0.00221	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—PTH—nephrolithiasis	7.63e-05	0.0021	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—AGXT—nephrolithiasis	7.55e-05	0.00208	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GRHPR—nephrolithiasis	7.12e-05	0.00196	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	7.1e-05	0.00196	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	7.08e-05	0.00195	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	7.01e-05	0.00193	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—DGKH—nephrolithiasis	6.81e-05	0.00188	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.81e-05	0.00188	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	6.46e-05	0.00178	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—APRT—nephrolithiasis	6.42e-05	0.00177	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—SLC26A1—nephrolithiasis	6.42e-05	0.00177	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	6.38e-05	0.00176	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AGXT—nephrolithiasis	6.34e-05	0.00175	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GRHPR—nephrolithiasis	6.17e-05	0.0017	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	5.91e-05	0.00163	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	5.89e-05	0.00162	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	5.87e-05	0.00162	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	5.84e-05	0.00161	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	5.79e-05	0.0016	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AGXT—nephrolithiasis	5.5e-05	0.00151	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—APRT—nephrolithiasis	5.39e-05	0.00149	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	5.39e-05	0.00149	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	5.37e-05	0.00148	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	5.35e-05	0.00147	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	5.3e-05	0.00146	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GRHPR—nephrolithiasis	5.06e-05	0.00139	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CHRM3—nephrolithiasis	4.93e-05	0.00136	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	4.8e-05	0.00132	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.8e-05	0.00132	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	4.78e-05	0.00132	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.78e-05	0.00132	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	4.73e-05	0.0013	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.73e-05	0.0013	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—APRT—nephrolithiasis	4.67e-05	0.00129	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	4.67e-05	0.00129	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—AQP1—nephrolithiasis	4.57e-05	0.00126	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AGXT—nephrolithiasis	4.51e-05	0.00124	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PTH—nephrolithiasis	4.5e-05	0.00124	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AQP1—nephrolithiasis	3.84e-05	0.00106	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—APRT—nephrolithiasis	3.84e-05	0.00106	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	3.84e-05	0.00106	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CHRM3—nephrolithiasis	3.48e-05	0.000958	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	3.47e-05	0.000955	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	3.42e-05	0.000943	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AQP1—nephrolithiasis	3.33e-05	0.000917	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GRHPR—nephrolithiasis	3.31e-05	0.000912	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PTH—nephrolithiasis	3.17e-05	0.000874	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PTH—nephrolithiasis	3.16e-05	0.000871	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PTH—nephrolithiasis	3.13e-05	0.000863	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CHRM3—nephrolithiasis	3.01e-05	0.00083	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AGXT—nephrolithiasis	2.95e-05	0.000813	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AQP1—nephrolithiasis	2.73e-05	0.000753	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	2.51e-05	0.000691	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APRT—nephrolithiasis	2.51e-05	0.000691	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CHRM3—nephrolithiasis	2.47e-05	0.000681	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—SPP1—nephrolithiasis	2.26e-05	0.000623	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AQP1—nephrolithiasis	1.79e-05	0.000492	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CHRM3—nephrolithiasis	1.62e-05	0.000445	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	1.59e-05	0.000439	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	1.59e-05	0.000437	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	1.57e-05	0.000433	CbGpPWpGaD
